Charlie Harper
Contact information
Colleges
Charlie Harper
BSc, MSc, DPhil
Trial Data Scientist
Charlie is a data scientist working in the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) at Oxford Population Health.
His work aims to develop new trial methods to streamline large-scale randomised trials that produce reliable answers, including the use of healthcare systems data to recruit and follow-up participants. He lectures on the University of Oxford's MSc in Clinical Trials and MSc in Global Health Science and Epidemiology.
Charlie completed his undergraduate degree in Economics at the University of East Anglia and MSc in Economics at Bristol University. He obtained his DPhil in Population Health from Oxford Population Health, where he showed that UK healthcare systems data can be used to reliably follow-up participants in large cardiovascular trials.
Recent publications
-
Joint associations of device-measured physical activity and sleep duration with incident major adverse cardiovascular events: prospective analysis of the UK Biobank
Preprint
Brocklebank L. et al, (2025)
-
Active Monitoring for AtriaL FIbrillation (AMALFI): rationale, protocol, and pilot for a pragmatic, randomized, controlled trial of remote screening for asymptomatic atrial fibrillation.
Journal article
Wijesurendra R. et al, (2025), Am Heart J
-
Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2025), Lancet Infect Dis
-
Association of Daily Steps with Incident Non-Alcoholic Fatty Liver Disease: Evidence from the UK Biobank Cohort.
Journal article
Fulda ES. et al, (2025), Med Sci Sports Exerc
-
Predictive performance of wearable sensors for mortality risk in older adults: a model development and validation study
Preprint
Harper C. et al, (2025)